Literature DB >> 10700064

Transcatheter coil occlusion of the small patent ductus arteriosus (<4 mm): improved results with a "multiple coil-no residual shunt" strategy.

T M Zellers1, K D Wylie, L Moake.   

Abstract

We report our experience with transcatheter occlusion of the small PDA using Gianturco coils comparing a single coil strategy to a "multiple coil-no residual shunt strategy". Fifteen patients (Group I) had a single coil only placed irrespective of residual shunting and 20 (Group II) were treated using the no residual shunt strategy. Age, minimal PDA diameter, PDA length and PDA types were similar between groups. Closure rates in Group I patients were 60%, 80% and 87% at <1 month, 6 months and 1 year, respectively. In Group II, the <1 month and 6 month closure rates were 100%. The costs and hospital charges for coil closure were comparable to a concurrent surgical group; the total charges (hospital plus physician) were less for Group I, but similar between Group II and the surgical group. The complication rate for coil closure was significantly less than surgical closure. From these data, transcatheter closure with multiple coils can achieve the same closure rate as surgery at similar hospital charges with fewer complications.

Entities:  

Mesh:

Year:  2000        PMID: 10700064     DOI: 10.1002/(sici)1522-726x(200003)49:3<307::aid-ccd17>3.0.co;2-m

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  2 in total

1.  Prediction of ductus arteriosus closure by neonatal screening echocardiography.

Authors:  Sheng-Ling Jan; Betau Hwang; Yun-Ching Fu; Ching-Shiang Chi
Journal:  Int J Cardiovasc Imaging       Date:  2004-08       Impact factor: 2.357

2.  Outcomes Associated with the Off-label Use of Medical Devices in Congenital Heart Disease at a Single Institute.

Authors:  Young Hwa Kong; Jinyoung Song; Jun Huh; I-Seok Kang
Journal:  Korean Circ J       Date:  2017-07-27       Impact factor: 3.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.